scholarly journals Comment on “Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma”

2015 ◽  
pp. 2321
Author(s):  
Abdullah Abdullah KAYA ◽  
yakup aksoy ◽  
mehmet koray sevinç ◽  
Oktay Diner
Keyword(s):  
Primary Open Angle Glaucoma ◽  
Open Angle Glaucoma ◽  
Open Angle ◽  
Short Term ◽  
Short Term Effects

scholarly journals Short-Term Results of Canaloplasty Surgery for Primary Open-Angle Glaucoma in Japanese Patients

2011 ◽  
Vol 2 (1) ◽  
pp. 65-68 ◽  
Author(s):  
Kazuya Fujita ◽  
Kiyotaka Kitagawa ◽  
Yoshiki Ueta ◽  
Tomoko Nakamura ◽  
Akio Miyakoshi ◽  
...  
Keyword(s):  
Primary Open Angle Glaucoma ◽  
Open Angle Glaucoma ◽  
Japanese Patients ◽  
Open Angle ◽  
Short Term

scholarly journals Assessment of short-term intraocular pressure parameters in phakic and pseudophakic patients with primary open-angle glaucoma

2021 ◽  
Vol 84 (5) ◽  
Author(s):  
Adriana Sobral Lourenço ◽  
Candice Cristina Quirino de Araújo ◽  
Procópio Miguel dos Santos ◽  
Tiago S. Prata ◽  
Nara Lidia Vieira Lopes ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Primary Open Angle Glaucoma ◽  
Open Angle Glaucoma ◽  
Open Angle ◽  
Short Term

scholarly journals Early Experience with the New XEN63 Implant in Primary Open-Angle Glaucoma Patients: Clinical Outcomes

2021 ◽  
Vol 10 (8) ◽  
pp. 1628
Author(s):  
Antonio Maria Fea ◽  
Martina Menchini ◽  
Alessandro Rossi ◽  
Chiara Posarelli ◽  
Lorenza Malinverni ◽  
...  
Keyword(s):  
Primary Open Angle Glaucoma ◽  
Open Angle Glaucoma ◽  
Real Life ◽  
Glaucoma Surgery ◽  
Open Angle ◽  
Short Term ◽  
Serious Adverse Events ◽  
Primary Endpoints ◽  
Limited Experience ◽  
Mean Time

The new XEN63 implant is a minimally invasive glaucoma surgery device with limited experience in real life. This retrospective study included open-angle glaucoma patients who underwent XEN63 implant, either alone or in combination with cataract surgery. Primary endpoints were the intraocular pressure (IOP) at month 3 and the incidence of serious adverse events. Twenty-three eyes of 23 patients were included. Mean age was 67.8 ± 15.3 years and 15 (65.2%) were women. Mean IOP was significantly lowered from 27.0 ± 7.8 mmHg at baseline to 12.2 ± 3.4 mmHg at month 3 (p < 0.0001). Mean IOP lowering was 40.8 ± 23.5%, with 14 (60.9%) and 16 (69.6%) eyes achieving an IOP lowering ≥30% and ≥20% without hypotensive medication, respectively. The number of hypotensive medications (NHM) was significantly reduced from 2.27 ± 0.94 drugs at baseline to 0.09 ± 0.42 drugs at month 3, p < 0.0001. Four (17.4%) eyes had hypotony (IOP ≤ 6 mmHg) at postoperative day one, which was successfully resolved without sequelae. Four (17.4%) eyes had choroidal detachment (3 at day 7 and 1 at day 15), which was successfully resolved with medical treatment, at the month 1 visit. Three (13.0%) eyes required needling (mean time for needling 35.6 ± 9.7 days). XEN63 significantly lowered IOP and reduced the NHM, with a good short-term safety profile.

Sign in / Sign up

Export Citation Format

Share Document